Tauro-obeticholic acid

863239-61-6

12352211

H302, H315, H319, H335

FXR

Reference compound

Metabolic Enzyme/Protease

COVID-19-immunoregulation

Inflammation/Immunology

https://www.medchemexpress.com/tauro-obeticholic-acid.html

98.2

10 mM in DMSO

C[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C

C28H49NO6S

527.76

H302, H315, H319, H335

[1]Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76 (12) :1221-6.

Blue Ice

-20°C (Powder, protect from light, stored under nitrogen)

Reference compound1

No Development Reported